NCT04726787View on ClinicalTrials.gov

RadiothErapy priMIng for CAR-T

NAActive, not recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 18, 2022

Primary Completion Date

July 5, 2023

Study Completion Date

June 30, 2025

Conditions
Diffuse Large B Cell Lymphoma
Interventions
RADIATION

Bridging Radiotherapy

Bridging Radiotherapy will start immediately after leukapheresis and before Tisagenlecleucel treatment

Trial Locations (3)

Unknown

St James's University Hospital, Leeds

Kings College Hospital, London

Freeman Hospital, Newcastle

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University College, London

OTHER